BEVACOMB

Main information

  • Trade name:
  • BEVACOMB 5 mg / 160 mg film-coated tablet
  • Dosage:
  • 5 mg / 160 mg
  • Pharmaceutical form:
  • film-coated tablet
  • Prescription type:
  • Prescription only
  • Medicine domain:
  • Humans
  • Medicine type:
  • Allopathic drug

Documents

Localization

  • Available in:
  • BEVACOMB 5 mg / 160 mg film-coated tablet
    Finland
  • Language:
  • English

Therapeutic information

  • Therapeutic area:
  • Valsartan and amlodipine
  • Product summary:
  • Previous_names: BEVACOMP; Suitability for use in older adult patients Valsartanum Suitable for older persons, with specific cautions. Ensure adequate fluid balance before starting treatment. Monitor renal function during the pharmacotherapy. Avoid concurrent use of anti-inflammatory analgesics. Amlodipini besilas Suitable for older persons. Significant adverse effects include ankle oedema and orthostatic hypotension. Take interactions into account. Avoid consuming grapefruit juice during treatment.

Other information

Status

  • Source:
  • Fimea
  • Authorization status:
  • Marketing authorization granted
  • Authorization number:
  • 33086
  • Last update:
  • 26-07-2018